Bivalent inactivated vaccine for hemorrhagic fever with renal syndrome (gerbil kidney cells)

Used to prevent type Ⅰ and type Ⅱ hemorrhagic fever with renal syndrome.

There are few adverse reactions after injection. Individuals with fever, dizziness, and rash should be carefully observed and given appropriate treatment if necessary. Because the vaccine contains aluminum hydroxide adjuvant, a few people may experience local nodules, mild swelling, and pain after injection, which generally disappear on their own within 1-3 days.

1. It is contraindicated for those with fever, acute disease, severe chronic disease, nervous system disease, allergic disease, or previous allergy to antibiotics or biological products; 2. It is contraindicated for breastfeeding women and pregnant women.

Precautions during pregnancy and lactation: It is forbidden to use for women during lactation and pregnant women.

Store and transport at 2-8℃ away from light.

Each bottle contains 1.0 ml. The human dose is 1.0 ml.

24 months

Zhejiang Tianyuan Bio-pharmaceutical Co., Ltd.

• Founded in:

  1986-12-19

• Address:

  No. 56, Tianhe Road, Economic and Technological Development Zone, Linping District, Hangzhou City, Zhejiang Province

• Tax NO.:

  91330000143833309Q

• Registered Funds:

  1,066.8 million yuan

• Website:

  Log in to view

• Email:

  Log in to view